Skip to main content
← All data ties

Cardiovascular Diseases Research in Rhode Island

USAspending.gov lists $159,771,343.94 in Cardiovascular Diseases Research obligations (CFDA 93.837) with Rhode Island place of performance, across 108 awards. One hundred eight instruments against that dollar figure imply about $1,479,364.30 per award. This page is a JOIN of the program catalog to RI. It is not a patient census, a lab inventory, or a named-investigator roster. Obligations are not outlays.

Key figures

  • CFDA 93.837 shows $159,771,343.94 in Rhode Island obligations on 108 awards.
  • The mean is about $1,479,364.30 per award.
  • The catalog is Cardiovascular Diseases Research, not a patient census, a lab inventory, or a named-investigator roster.
  • Rhode Island is a place-of-performance tag, not a unit census.
  • Figures are obligations, not outlays.

The 93.837–Rhode Island intersection

The cell sums award obligations with CFDA 93.837 and a RI place-of-performance tag. $159,771,343.94 is that sum. It is not a ranking of Rhode Island against other states. Campaign-finance tables are a different dataset; FEC donations do not fund these USAspending obligations.

One hundred eight awards is a multi-project extramural file: research assistance often posts as about a hundred discrete records rather than one statewide block. The join does not name recipients. Packet facts are $159,771,343.94, 108 awards, RI, and 93.837. Correlation is not causation. FEC donations do not fund this USAspending cell. Keep Cardiovascular diseases research and Rhode Island together when reading $159,771,343.94.

Heart-disease research as a listing, not a clinic file

CFDA 93.837 is CARDIOVASCULAR DISEASES RESEARCH. Packet facts on the program side stop at the name Cardiovascular Diseases Research, the number 93.837, $159,771,343.94, and 108 awards. This packet lists no award recipients and no contractor names. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a combined total the packet never computed. CARDIOVASCULAR DISEASES RESEARCH is the catalog title. One hundred eight awards is a multi-project extramural file: research assistance often posts as about a hundred discrete records rather than one statewide block. The join does not convert dollars into labs, investigators, or patients. Neighbor-state Cardiovascular diseases research joins are other pairs.

Cardiovascular Diseases Research is not an allergy-research twin and not an addiction-research twin. Those are other CFDA numbers. One hundred eight records against $159,771,343.94 do not name principal investigators. A 93.837 award tagged to Massachusetts stays outside this Rhode Island cell even if a lab collaboration crosses the border.

Rhode Island place of performance on 93.837

Place of performance in Rhode Island is a USAspending geography field. Providence, Warwick, or Newport folklore may send a reader here; those stories are not a metro split in this packet. Awards can list RI while later work occurs elsewhere. Neighbor codes (Massachusetts and Connecticut) stay outside $159,771,343.94. Place of performance can differ from where a recipient is headquartered. This packet does not publish either split. Neighbor-state Cardiovascular diseases research joins are other pairs, not addends.

One hundred eight awards, not 108 named labs

108 is the award-record count. It is not 108 labs, investigators, or patients. A mean of about $1,479,364.30 if $159,771,343.94 were divided evenly across 108 lines is arithmetic, not a typical payment. Unique vendors are unpublished. Treat one hundred eight as a record count, not a unit census. A later USAspending ingest can restate both $159,771,343.94 and the 108-award count without changing the join keys. Agency splits are omitted from this packet. No fiscal year is in the facts, so none is cited here.

Citing cardiovascular research in Rhode Island

Keep $159,771,343.94 labeled as obligations. Outlays, remaining balances, and recipient names are unpublished. The join is not a patient census, a lab inventory, or a named-investigator roster. Quote Cardiovascular Diseases Research and Rhode Island together. Later bulk files can move both the dollars and the 108-award count. Campaign-finance tables do not fund these USAspending obligations. Unique recipients remain unpublished on this Cardiovascular Diseases Research Rhode Island join.

Use /states/ri/programs/93.837/ (Cardiovascular Diseases Research in Rhode Island) for the overlay, /programs/93.837/ (CFDA 93.837) for the listing, /states/ri/ (Rhode Island federal spending) for the state hub, /states/ri/programs/ (Rhode Island programs) for the program index, and /ties/ (All spending ties) for other pairs. Cite CFDA 93.837, Rhode Island, $159,771,343.94, USAspending.gov, obligations only. Keep Cardiovascular Diseases Research and Rhode Island together when citing $159,771,343.94. CFDA 93.837 lists 108 award records on this RI join. Obligations of $159,771,343.94 are not outlays. Original filings remain on USAspending.gov for this CFDA 93.837 × RI pair. Do not add parent hubs into this state-program cell. Quote CFDA 93.837, Rhode Island, and $159,771,343.94 in one sentence. The Rhode Island programs index and All spending ties index are larger than this cell. This page is not a patient census, a lab inventory, or a named-investigator roster. 108 award records are not 108 labs, investigators, or patients. Mean dollars per action remain about $1,479,364.30 if you divide those two facts. RI is place of performance, not a split of Providence, Warwick, or Newport. Cardiovascular Diseases Research is not an allergy-research twin and not an addiction-research twin. Those are other CFDA numbers. One hundred eight records against $159,771,343.94 do not name principal investigators. A 93.837 award tagged to Massachusetts stays outside this Rhode Island cell even if a lab collaboration crosses the border. Source note: USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.

Questions

How much Cardiovascular diseases research funding is obligated in Rhode Island?
USAspending.gov records $159,771,343.94 in CFDA 93.837 obligations with Rhode Island place of performance on 108 awards. That is the pair total, not an outlay and not a patient census, a lab inventory, or a named-investigator roster. Keep Cardiovascular Diseases Research and Rhode Island together when citing $159,771,343.94.
Do 108 awards mean 108 Rhode Island laboratories?
No. 108 is a USAspending award-record count, not 108 labs, investigators, or patients. The implied mean is about $1,479,364.30 per award. Unique recipients are unpublished. Obligations of $159,771,343.94 are not outlays. USAspending.gov remains the source for this 93.837 × RI pair.
Is this Rhode Island’s full federal health-research spend?
No. $159,771,343.94 is only the CFDA 93.837 × Rhode Island cell. Other catalogs appear on separate Rhode Island program pages. Nationwide 93.837 is not limited to Rhode Island. Mixing this listing with other health-research catalog lines that use different CFDA numbers would invent a larger total.
Where is the live 93.837 × Rhode Island table?
Cardiovascular Diseases Research in Rhode Island is the overlay at /states/ri/programs/93.837/. CFDA 93.837 is /programs/93.837/. Rhode Island federal spending is /states/ri/. Rhode Island programs is /states/ri/programs/. All spending ties is /ties/. Original filings remain on USAspending.gov for this 93.837 × RI pair.

USAspending.gov CFDA program aggregates by place of performance state. Obligations are not outlays.